craniocerebral trauma~|~headache~|~ankle injuries~|~specific qualifier value~|~headache, ctcae~|~injury of shoulder and upper arm~|~to specify~|~nausea and vomiting
crest syndrome~|~cardiac arrest~|~cardiac arrest, ctcae 5~|~crest~|~ridging~|~ss18l1 gene~|~ss18l1 wt allele~|~specific qualifier value~|~crest - location
nausea~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~irritation~|~irritation (finding)~|~irritation - emotion~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~usual severity nausea~|~generalized abdominal pain
not otherwise specified
national institute on aging (u.s.)~|~china~|~nausea~|~specific qualifier value~|~heart~|~bothered by nausea~|~cardiac - anatomy qualifier~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~nia (fungus)~|~nias language~|~this (eukaryote)~|~usual severity nausea~|~worried~|~nausea and vomiting
pneumonia~|~communicable diseases~|~face~|~facial~|~fighting~|~infectious disease pathway~|~mental status change~|~not otherwise specified~|~organism~|~specific qualifier value~|~stress
infarction~|~massive~|~mark1 gene~|~mark1 wt allele~|~specific qualifier value~|~mark - attribute
sepsis~|~septicemia~|~fever~|~organism~|~sepsis (invertebrate)~|~sepsis, ctcae~|~specific qualifier value~|~fever symptoms (finding)~|~fever, ctcae~|~right upper quadrant pain
hac protocol~|~disease~|~not otherwise specified~|~changed status~|~changing~|~hadh gene~|~have~|~hope (emotion)~|~mental status change~|~middle~|~midline (qualifier value)~|~status~|~structure of median lobe of prostate~|~table cell vertical align - middle~|~unspecified injury of abdomen~|~what subject filter - status~|~definitely related to intervention~|~relate - vinyl resin~|~related personal status~|~relationships~|~role link type - related
syncope~|~andorra~|~cardiac arrest~|~and~|~and - dosing instruction fragment~|~cardiac arrest, ctcae 5~|~relationshipconjunction - and~|~suicide attempt incident code~|~suicide attempt, ctcae~|~suicide attempt
nurse administrator~|~diazooxonorleucine~|~dyspnea~|~chronic obstructive airway disease~|~disease~|~membrane~|~membrane device~|~not otherwise specified~|~tissue membrane
mental status change~|~not otherwise specified
infarction~|~veterinarian~|~fascia~|~face~|~italy~|~entire fascia~|~facial~|~have~|~status~|~what subject filter - status~|~veterinary aspects~|~intrathecal route of drug administration
pain~|~chest pain~|~deterioration of status~|~not otherwise specified~|~observation interpretation - worse~|~worse~|~worsening pattern~|~chest pain:finding:point in time:^patient:ordinal~|~pain in lower limb
congestive heart failure~|~diastole~|~systole~|~dyspnea~|~andorra~|~and~|~and - dosing instruction fragment~|~combined~|~congestive~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~not otherwise specified~|~relationshipconjunction - and~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~chronic~|~chronic - admission level of care code~|~provision of recurring care for chronic illness
hypoglycemia~|~hypoglycemia, ctcae~|~specific qualifier value
headache~|~headache, ctcae
pain~|~headache~|~andorra~|~pelvis~|~specific qualifier value~|~head~|~and~|~and - dosing instruction fragment~|~entire head~|~head - component of device~|~headache, ctcae~|~injury of shoulder and upper arm~|~relationshipconjunction - and~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~unspecified injury of hip~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
chronic obstructive airway disease~|~andorra~|~disease~|~adult~|~membrane~|~and~|~and - dosing instruction fragment~|~chest pain on breathing~|~high~|~highway environment~|~member organization~|~membrane device~|~not otherwise specified~|~relationshipconjunction - and~|~role class - member~|~tissue membrane~|~member~|~adult disease~|~legal adult
mental status change~|~not otherwise specified
bradycardia~|~cardiac arrhythmia~|~not otherwise specified~|~changed status~|~changing~|~adverse event associated with cardiac arrhythmia~|~change -- procedure~|~delta (difference)~|~mental status change~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~physical aggression
seizures~|~respiratory failure~|~fecal immunochemical test~|~fit (action)~|~fit and well~|~not otherwise specified~|~prosthesis fit~|~respiratory failure, ctcae~|~specific qualifier value
infarction~|~italy~|~headache~|~role~|~intrathecal route of drug administration~|~signs and symptoms~|~attack behavior~|~generic role~|~headache, ctcae~|~in transit~|~nci thesaurus role~|~observation of attack~|~onset of illness~|~security role object~|~social role~|~specific qualifier value~|~terminology role entity~|~role - roleclass~|~general symptom
apnea~|~poisoning~|~not otherwise specified~|~accidents~|~opiate alkaloids~|~opiates~|~metals~|~accidental~|~apnea, ctcae~|~butting~|~changed status~|~changing~|~encounter~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~mental status change~|~opiate assay~|~patient visit~|~status~|~unintentional~|~visit~|~what subject filter - status~|~poisoning aspects
mental orientation~|~asians~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~cdisc adas-cog - orientation summary score~|~genomic orientation~|~mental status change~|~montreal cognitive assessment orientation test~|~not otherwise specified~|~orientation (spatial)~|~suicidal~|~this (eukaryote)
helium~|~nurse administrator~|~diazooxonorleucine~|~membrane~|~disease~|~smoking~|~membrane device~|~tissue membrane~|~gases~|~beta-hemolytic streptococcus, group a~|~corsican language~|~cos (greek island)~|~elation~|~encounter~|~firstly~|~galns gene~|~gast gene~|~gast wt allele~|~gas - specimen source codes~|~gas - specimentype~|~gas dosage form~|~healthcare encounter~|~high~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~pagr1 gene~|~pagr1 wt allele~|~patient visit~|~specific qualifier value~|~structure of collateral sulcus~|~toxic effect~|~vapor~|~visit~|~gastrointestinal gas~|~germacrene-a synthase activity~|~cytip gene~|~determined by~|~location characteristic id - smoking~|~medical device emits smoke~|~tobacco smoking behavior
pain~|~homo sapiens~|~cardiac arrhythmia~|~males~|~specific qualifier value~|~adverse event associated with cardiac arrhythmia~|~external cause codes: unspecified~|~male population group~|~man chinese~|~mandinka language~|~this (eukaryote)~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~nausea and vomiting~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
syncope~|~andorra~|~disease~|~adult~|~membrane~|~and~|~and - dosing instruction fragment~|~high~|~membrane device~|~relationshipconjunction - and~|~tissue membrane~|~legal adult
united arab emirates~|~italy~|~specific qualifier value~|~androgen response element~|~approximate~|~fracture~|~fracture of medical device material~|~fracture, ctcae~|~not otherwise specified~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~are unit of measure~|~intrathecal route of drug administration~|~july~|~superficial injury
best1 gene~|~purchase~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~best (quality)~|~body site modifier - external~|~code system type - external~|~external route~|~extrinsic
vision~|~dyspnea~|~disease~|~membrane~|~skin~|~entire skin~|~function (attribute)~|~function axis~|~functional status scoring systems~|~have~|~have shortness of breath question~|~high~|~how much distress shortness of breath~|~how often shortness of breath~|~mathematical operator~|~membrane device~|~see~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~skin specimen~|~skin specimen source code~|~skin, human~|~specific qualifier value~|~tissue membrane~|~usual severity shortness of breath~|~won~|~physiological aspects
hemorrhage~|~not otherwise specified~|~tests (qualifier value)~|~blood products laboratory testing~|~laboratory procedures~|~test - temporal region~|~test dosing unit~|~test name~|~test result~|~testing
nausea~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~usual severity nausea
il10 protein, human~|~signs and symptoms~|~il10 gene~|~in addition to~|~specific qualifier value~|~tgif1 gene~|~tgif1 wt allele~|~to specify~|~with - dosing instruction fragment~|~aggressive behavior~|~fever with chills~|~general symptom
pain~|~dyspnea~|~emotional tenderness~|~generalized~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~sore to touch~|~specific qualifier value~|~usual severity shortness of breath~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
infarction~|~tachycardia~|~italy~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~mental disorders~|~not otherwise specified~|~intrathecal route of drug administration
tachycardia~|~chest pain~|~progressive encephalomyelitis with rigidity~|~peru~|~anxiety~|~respiration~|~not otherwise specified~|~anxiety disorders~|~anxiety hyperventilation~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~environmental air flow~|~follow~|~per tumor staging notation~|~per1 gene~|~per1 wt allele~|~per (qualifier)~|~per - dosing instruction fragment~|~ventilation, function (observable entity)~|~chest pain:finding:point in time:^patient:ordinal~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
helping behavior~|~lif protein, human~|~vomiting~|~aspects of mortality statistics~|~assisted (qualifier value)~|~at home~|~corsican language~|~cos (greek island)~|~dcstamp gene~|~device status unkown~|~finding~|~hilda <invertebrate>~|~lif gene~|~lif wt allele~|~marital status - unknown~|~mortality vital statistics~|~no other household member able to render care~|~patient need for (contextual qualifier)~|~specific qualifier value~|~structure of collateral sulcus~|~unknown~|~unknown - administrative gender~|~unknown - allergy severity~|~unknown - cwe statuses~|~unknown - contact role~|~unknown - container status~|~unknown - employment status~|~unknown - escort required~|~unknown - ethnic group~|~unknown - event expected~|~unknown - event reason~|~unknown - expanded yes/no indicator~|~unknown - hl7 update mode~|~unknown - immunization registry status~|~unknown - job status~|~unknown - living arrangement~|~unknown - living dependency~|~unknown - living will code~|~unknown - notify clergy code~|~unknown - organ donor code~|~unknown - patient class~|~unknown - patient condition code~|~unknown - patient outcome~|~unknown - patient_s relationship to insured~|~unknown - precaution code~|~unknown - production class code~|~unknown - recreational drug use code~|~unknown - relationship~|~unknown - religion~|~unknown - special program code~|~unknown - transport arranged~|~unknown - vaccines administered~|~unknown - mode of arrival code~|~unknown - publishing section~|~unknown data entry method~|~unknown dosage form category~|~unknown genc~|~unknown mechanism of action~|~unknown publicity code~|~unknown route of drug administration~|~unknown transformation~|~unknown - nullflavor~|~unknown vaccine or immune globulin~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
poverty~|~poisoning~|~mental orientation~|~nausea~|~andorra~|~opiate alkaloids~|~opiates~|~signs and symptoms~|~and~|~and - dosing instruction fragment~|~bothered by nausea~|~butting~|~cdisc adas-cog - orientation summary score~|~changed status~|~changing~|~feel nausea~|~genomic orientation~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~ifng-as1 gene~|~international metastatic renal cell carcinoma database consortium (imdc) criteria - poor-risk group~|~language proficiency - poor~|~middle~|~midline (qualifier value)~|~montreal cognitive assessment orientation test~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~not otherwise specified~|~opiate assay~|~orientation (spatial)~|~patient condition code - poor~|~poor - grade value~|~poor - qualifier~|~relationshipconjunction - and~|~responsive~|~specific qualifier value~|~specimen quality - poor~|~status~|~structure of median lobe of prostate~|~table cell vertical align - middle~|~this (eukaryote)~|~usual severity nausea~|~what subject filter - status~|~determined by~|~general symptom~|~poisoning aspects
have~|~application (document)~|~application dosing unit~|~application dose~|~application procedure~|~apply~|~computer application~|~external cause codes: unspecified~|~hl7 version 2.5 - application~|~news [publication type]~|~not otherwise specified~|~possess~|~regulatory application~|~tension~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness
mental status change~|~not otherwise specified~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
poverty~|~opioid-related disorders~|~andorra~|~and~|~and - dosing instruction fragment~|~clinical observation~|~disease response~|~encounter~|~facilitated oscillatory release technique~|~healthcare encounter~|~international metastatic renal cell carcinoma database consortium (imdc) criteria - poor-risk group~|~language proficiency - poor~|~observation - diagnostic procedure~|~observation in research~|~observation regimes~|~patient condition code - poor~|~patient visit~|~patient observation~|~poor - grade value~|~poor - qualifier~|~preposition for~|~relationshipconjunction - and~|~response (communication)~|~response (statement)~|~response process~|~specialty type - observation~|~specific qualifier value~|~specimen quality - poor~|~this (eukaryote)~|~visit~|~wwox gene~|~wwox wt allele~|~act - observation
classification~|~facial pain~|~hac protocol~|~face~|~acute onset pain~|~difficult (qualifier value)~|~elovl6 gene~|~entire face~|~fance wt allele~|~fanconi anemia, complementation group e~|~face (spatial concept)~|~hadh gene~|~has difficulty doing (qualifier value)~|~have~|~nr4a2 gene~|~negation~|~not otherwise specified~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~facial pain, ctcae
dyspnea~|~disease~|~membrane~|~facilitated oscillatory release technique~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~membrane device~|~order (action)~|~order (arrangement)~|~order (document)~|~order (record artifact)~|~order (taxonomic)~|~order [pk]~|~permutation~|~preposition for~|~sequence of planned assessment schedule~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~specimen source codes - respiratory~|~this (eukaryote)~|~tissue membrane~|~to specify~|~usual severity shortness of breath~|~wwox gene~|~wwox wt allele~|~what subject filter - order~|~respiratory
craniocerebral trauma~|~headache~|~specific qualifier value~|~headache, ctcae~|~lupus erythematosus tumidus~|~not otherwise specified~|~traumatic and/or non-traumatic injury~|~traumatic injury
hyperglycemia~|~dehydration~|~diabetes mellitus~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~unspecified~|~signs and symptoms~|~dehydration procedure~|~dehydration, ctcae~|~external cause codes: unspecified~|~in addition to~|~not otherwise specified~|~undifferentiated sex~|~unspecified - name type~|~unspecified method of administration~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~general symptom
asthma~|~text messaging~|~wheezing~|~specific qualifier value~|~asthma pathway~|~in addition to~|~not otherwise specified~|~with - dosing instruction fragment~|~wheezing, ctcae
psychomotor agitation~|~restlessness~|~knowledge acquisition~|~nervousness~|~symptoms~|~hallucinations, visual~|~anxiety~|~educational status~|~anxiety disorders~|~agitation~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~details of education~|~educational aspects~|~educational process of instructing~|~emotional well-being~|~emotional state observations~|~emotional states~|~feeling nervous~|~involvement with~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~restlessness, ctcae~|~specialty type - education~|~specific qualifier value~|~symptoms aspect~|~aspects of signs~|~chronic - admission level of care code~|~manufactured sign~|~physical findings~|~provision of recurring care for chronic illness~|~chronic
pain~|~andorra~|~and~|~and - dosing instruction fragment~|~kalmia~|~relationshipconjunction - and~|~specific qualifier value~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
respiratory failure~|~lung diseases, obstructive~|~external cause codes: unspecified~|~like~|~not otherwise specified~|~respiratory failure, ctcae~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness
lif protein, human~|~respiratory failure~|~cyanosis~|~shock~|~dcstamp gene~|~finding~|~beak~|~corsican language~|~cos (greek island)~|~cyanosis, ctcae~|~device status unkown~|~hilda <invertebrate>~|~lif gene~|~lif wt allele~|~marital status - unknown~|~respiratory failure, ctcae~|~specific qualifier value~|~structure of collateral sulcus~|~unknown~|~unknown - administrative gender~|~unknown - allergy severity~|~unknown - cwe statuses~|~unknown - contact role~|~unknown - container status~|~unknown - employment status~|~unknown - escort required~|~unknown - ethnic group~|~unknown - event expected~|~unknown - event reason~|~unknown - expanded yes/no indicator~|~unknown - hl7 update mode~|~unknown - immunization registry status~|~unknown - job status~|~unknown - living arrangement~|~unknown - living dependency~|~unknown - living will code~|~unknown - notify clergy code~|~unknown - organ donor code~|~unknown - patient class~|~unknown - patient condition code~|~unknown - patient outcome~|~unknown - patient_s relationship to insured~|~unknown - precaution code~|~unknown - production class code~|~unknown - recreational drug use code~|~unknown - relationship~|~unknown - religion~|~unknown - special program code~|~unknown - transport arranged~|~unknown - vaccines administered~|~unknown - mode of arrival code~|~unknown - publishing section~|~unknown data entry method~|~unknown dosage form category~|~unknown genc~|~unknown mechanism of action~|~unknown publicity code~|~unknown route of drug administration~|~unknown transformation~|~unknown - nullflavor~|~unknown vaccine or immune globulin
china~|~heart~|~cardiac - anatomy qualifier
poisoning~|~asians~|~pharmaceutical preparations~|~signs and symptoms~|~biological factors~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~change -- procedure~|~changed status~|~changing~|~decision~|~delta (difference)~|~drugs - dental services~|~in addition to~|~intoxication~|~medications~|~medications:-:point in time:^patient:-~|~medications:presence or identity:duration of the study:^patient:nominal~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified~|~specific qualifier value~|~suicidal~|~with - dosing instruction fragment~|~determined by~|~general symptom~|~poisoning aspects~|~symptoms and signs involving emotional state
poisoning~|~needs~|~andorra~|~pharmaceutical preparations~|~and~|~and - dosing instruction fragment~|~biological factors~|~butting~|~determined by~|~drugs - dental services~|~external cause codes: unspecified~|~medications~|~medications:-:point in time:^patient:-~|~medications:presence or identity:duration of the study:^patient:nominal~|~nr4a2 gene~|~negation~|~patient need for (contextual qualifier)~|~relationshipconjunction - and~|~sentence~|~slurred speech~|~tension~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~chronic~|~aspects of signs~|~chronic - admission level of care code~|~general medical service~|~generalized~|~manufactured sign~|~physical findings~|~poisoning aspects~|~provision of recurring care for chronic illness~|~safety reporting documentation~|~united states military commissioned officer o10
term birth~|~birth injuries~|~work~|~before~|~before values~|~pure spanish horse breed (organism)~|~photoreactivating enzyme activity~|~andorra~|~pregnancy trimesters~|~in addition to~|~reported term~|~term (lexical)~|~term (temporal)~|~with - dosing instruction fragment~|~labor (childbirth)~|~and~|~and - dosing instruction fragment~|~complication of delivery~|~home environment~|~house (environment)~|~relationshipconjunction - and~|~specific qualifier value~|~term pregnancy delivered~|~admission type - labor and delivery~|~encounter admission source - labor and delivery~|~labor and delivery facility~|~labor and delivery process
dyspnea~|~diabetes mellitus~|~hyperglycemia~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~choose (action)~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~in addition to~|~pick1 gene~|~pick1 wt allele~|~specific qualifier value~|~with - dosing instruction fragment
disease~|~membrane~|~departure - action~|~membrane device~|~tissue membrane~|~fever with chills
menogaril~|~multiple endocrine neoplasia~|~shoes~|~best1 gene~|~behavioral change~|~in addition to~|~mental status change~|~not otherwise specified~|~purchase~|~with - dosing instruction fragment~|~best (quality)~|~aggressive behavior~|~ell gene~|~ell wt allele~|~male population group~|~mende language
craniocerebral trauma~|~signs and symptoms~|~emotional well-being~|~emotional state observations~|~emotional states~|~evolving~|~external cause codes: unspecified~|~facilitated oscillatory release technique~|~late~|~late stage~|~pair~|~preposition for~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~wwox gene~|~wwox wt allele~|~rena
infarction~|~tajikistan~|~adult~|~skin~|~encounter~|~encounter due to unspecified general medical examination~|~entire skin~|~facilitated oscillatory release technique~|~health checkup~|~healthcare encounter~|~hill~|~medical examination~|~not otherwise specified~|~patient visit~|~preposition for~|~skin specimen~|~skin specimen source code~|~skin, human~|~specific qualifier value~|~surrey~|~visit~|~wwox gene~|~wwox wt allele~|~general symptom~|~language ability - sign~|~legal adult~|~physical findings~|~tujia chinese
headache~|~back pain~|~concussion without loss of consciousness~|~encounter~|~firstly~|~headache, ctcae~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~not otherwise specified~|~patient visit~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~visit~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~primary~|~primary operation~|~true primary (qualifier value)
sepsis~|~septicemia~|~organism~|~external cause codes: unspecified~|~is a~|~sepsis (invertebrate)~|~sepsis, ctcae~|~this (eukaryote)~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~bothered by night sweats~|~fever with chills~|~night sweats
disease~|~membrane~|~high~|~membrane device~|~tissue membrane
mental status change~|~not otherwise specified
dyspnea
metals~|~changed status~|~changing~|~not otherwise specified~|~status~|~what subject filter - status
cardiac arrhythmia~|~nausea~|~adverse event associated with cardiac arrhythmia~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~specific qualifier value~|~usual severity nausea
major depressive disorder~|~unipolar depression~|~specific qualifier value
tachycardia~|~cardiac arrhythmia~|~anxiety~|~disease~|~specific qualifier value~|~anxiety disorders~|~membrane~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~high~|~mia gene~|~membrane device~|~not otherwise specified~|~tissue membrane
asthma~|~dyspnea~|~asthma pathway~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~miles~|~miles pharmaceuticals~|~not otherwise specified~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~worried~|~antimicrobial intermediate susceptibility result~|~ipss-r risk category intermediate~|~intermediate~|~intermediate mitosis-karyorrhexis index~|~international metastatic renal cell carcinoma database consortium (imdc) criteria - intermediate-risk group~|~observation interpretation - intermediate
nurse administrator~|~diazooxonorleucine~|~classification~|~disease~|~fever~|~chills~|~adult~|~high~|~membrane~|~check~|~checking (action)~|~chills, ctcae~|~member organization~|~membrane device~|~nr4a2 gene~|~negation~|~role class - member~|~tissue membrane~|~member~|~1/3 meter (distance vision finding)~|~fever symptoms (finding)~|~fever, ctcae~|~legal adult~|~near
cardiac arrhythmia~|~adverse event associated with cardiac arrhythmia~|~specific qualifier value~|~worried
address~|~emotions~|~address (property)~|~address:address:point in time:^patient:nominal~|~addresses (publication format)~|~data types - address~|~emotional~|~geographic state~|~mdf attribute type - address~|~specific qualifier value~|~state~|~state ownership~|~stock (in-store merchandise)~|~us state~|~value type - address
craniocerebral trauma~|~multiple trauma~|~special~|~specific qualifier value~|~traumatic hemothorax~|~respiration intermittent
national institute on aging (u.s.)~|~nia (fungus)~|~nias language~|~specific qualifier value~|~this (eukaryote)
nurse administrator~|~vision~|~diazooxonorleucine~|~disease~|~membrane~|~andorra~|~membrane device~|~tissue membrane~|~and~|~and - dosing instruction fragment~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~decision~|~high~|~not otherwise specified~|~relationshipconjunction - and~|~see~|~fever with chills
helium~|~poisoning~|~accidents~|~morale~|~shock~|~respiration~|~pharmaceutical preparations~|~specific qualifier value~|~accidental~|~biological factors~|~collapse (finding)~|~collapse (morphologic abnormality)~|~collapse of device~|~drugs - dental services~|~expected date of confinement~|~external cause codes: unspecified~|~in addition to~|~medications~|~medications:-:point in time:^patient:-~|~medications:presence or identity:duration of the study:^patient:nominal~|~ubr5 gene~|~ubr5 wt allele~|~unintentional~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~breathing distress question~|~cytip gene~|~inspiration function~|~respiratory gaseous exchange in organisms
mental orientation~|~signs and symptoms~|~cdisc adas-cog - orientation summary score~|~change -- procedure~|~changed status~|~changing~|~delta (difference)~|~external cause codes: unspecified~|~genomic orientation~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~montreal cognitive assessment orientation test~|~not otherwise specified~|~orientation (spatial)~|~this (eukaryote)~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~determined by~|~general symptom~|~poisoning by cocaine
mental orientation~|~orientation (spatial)~|~cdisc adas-cog - orientation summary score~|~genomic orientation~|~montreal cognitive assessment orientation test~|~specific qualifier value
needs~|~bradycardia~|~not otherwise specified~|~patient need for (contextual qualifier)~|~signs and symptoms~|~general symptom
hyperglycemia~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae
retention (psychology)~|~needs~|~italy~|~specific qualifier value~|~science~|~time~|~retention - dental~|~cellular entity retention~|~not otherwise specified~|~patient need for (contextual qualifier)~|~retention of content~|~inches per second~|~data types - time~|~intrathecal route of drug administration~|~jonas~|~time (foundation metadata concept)~|~value type - time
infarction~|~italy~|~specific qualifier value~|~intrathecal route of drug administration
chest pain~|~chest pain:finding:point in time:^patient:ordinal
sitting position~|~ability to sit question~|~sitting function~|~specific qualifier value
craniocerebral trauma~|~best1 gene~|~purchase~|~specific qualifier value~|~best (quality)
cardiac arrhythmia~|~chest pain~|~andorra~|~anxiety~|~disease~|~adult~|~anxiety disorders~|~membrane~|~adverse event associated with cardiac arrhythmia~|~and~|~and - dosing instruction fragment~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~best1 gene~|~high~|~membrane device~|~not otherwise specified~|~relationshipconjunction - and~|~specific qualifier value~|~tissue membrane~|~to specify~|~best (quality)~|~chest pain:finding:point in time:^patient:ordinal~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease~|~legal adult
fitness~|~heart beat~|~specific qualifier value~|~ipss risk category low~|~ipss-r risk category low~|~low - messagewaitingpriority~|~low - observation~|~low level~|~low mitosis-karyorrhexis index~|~value below reference range~|~low~|~low confidentiality~|~low exposure
psychomotor agitation~|~restlessness~|~tea~|~poisoning~|~knowledge acquisition~|~nervousness~|~andorra~|~educational status~|~not otherwise specified~|~pharmaceutical preparations~|~biological science disciplines~|~emotions~|~agitation~|~and~|~and - dosing instruction fragment~|~details of education~|~drugs - dental services~|~educational aspects~|~educational process of instructing~|~emotional~|~external cause codes: unspecified~|~feeling nervous~|~feeling suicidal (finding)~|~geographic state~|~medications~|~medications:-:point in time:^patient:-~|~medications:presence or identity:duration of the study:^patient:nominal~|~mental status change~|~relationshipconjunction - and~|~restlessness, ctcae~|~specialty type - education~|~specific qualifier value~|~state~|~state ownership~|~stock (in-store merchandise)~|~stress~|~stress bismuth subsalicylate~|~suicidal ideation, ctcae~|~suicidal ideation:find:pt:^patient:nom~|~tea dosage form category~|~thoracic epidural analgesia~|~us state~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~w stress~|~determined by
dehydration~|~diarrhea~|~vertebral column~|~dehydration procedure~|~dehydration, ctcae~|~diarrhea, ctcae~|~entire spine~|~entire vertebral column~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~neuron spine~|~rear~|~side~|~specific qualifier value~|~usual severity diarrhea
needs~|~patient need for (contextual qualifier)~|~specific qualifier value
epilepsy~|~vomiting~|~wheezing~|~external cause codes: unspecified~|~in addition to~|~nr4a2 gene~|~negation~|~status~|~teacher~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~wedding~|~what subject filter - status~|~with - dosing instruction fragment~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~unresponsive to treatment~|~usual severity vomiting~|~vomiting, ctcae~|~wheezing, ctcae
back pain~|~chills~|~beaver indians~|~castor~|~chills, ctcae~|~in addition to~|~specific qualifier value~|~with - dosing instruction fragment~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~fever with chills
narcotics~|~poisoning~|~prostaglandin-endoperoxide synthase~|~mental orientation~|~electricity~|~nausea~|~ptgs1 protein, human~|~specific qualifier value~|~andorra~|~disease~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~decision~|~in addition to~|~pharmaceutical preparations~|~with - dosing instruction fragment~|~determined by~|~and~|~and - dosing instruction fragment~|~bothered by nausea~|~cdisc adas-cog - orientation summary score~|~cox8a gene~|~clinical services~|~cox microbiology subtype~|~drugs - dental services~|~electrical (qualifier value)~|~external cause codes: unspecified~|~feel nausea~|~genomic orientation~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~medications~|~medications:-:point in time:^patient:-~|~medications:presence or identity:duration of the study:^patient:nominal~|~montreal cognitive assessment orientation test~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~orientation (spatial)~|~relationshipconjunction - and~|~services~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~definitely related to intervention~|~relate - vinyl resin~|~related personal status~|~relationships~|~role link type - related
classification~|~cardiac arrhythmia~|~chest pain~|~adverse event associated with cardiac arrhythmia~|~specific qualifier value~|~chest pain:finding:point in time:^patient:ordinal~|~pay
nurse administrator~|~atrial fibrillation~|~diazooxonorleucine~|~disease~|~cardiac arrhythmia~|~andorra~|~high~|~membrane~|~adverse event associated with cardiac arrhythmia~|~and~|~and - dosing instruction fragment~|~atrial fibrillation by ecg finding~|~atrial fibrillation, ctcae~|~ever told you have or had atrial fibrillation:finding:point in time:^patient:ordinal~|~member organization~|~membrane device~|~mental status change~|~not otherwise specified~|~relationshipconjunction - and~|~role class - member~|~specific qualifier value~|~tissue membrane~|~to specify~|~member
tachycardia~|~epileptic syndromes~|~epilepsy~|~mental status change~|~not otherwise specified~|~generalized~|~in addition to~|~nr4a2 gene~|~negation~|~specific qualifier value~|~status~|~what subject filter - status~|~with - dosing instruction fragment~|~idiopathic epilepsy~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease~|~unresponsive to treatment
psychomotor agitation~|~restlessness~|~helium~|~nurse administrator~|~tachycardia~|~diazooxonorleucine~|~imagination~|~italy~|~agitation~|~high~|~restlessness, ctcae~|~tissue membrane~|~cytip gene~|~intrathecal route of drug administration~|~symptoms and signs involving emotional state
infarction~|~somnolence~|~mental status change~|~not otherwise specified~|~drowsiness~|~drowsiness visual analogue scale~|~external cause codes: unspecified~|~give - dosing instruction imperative~|~place~|~place - dosing instruction imperative~|~placement action~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~volt~|~volume administered~|~put - instruction imperative
helium~|~asthma~|~anxiety~|~anxiety disorders~|~actual aspiration~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~aspiration, ctcae~|~aspiration-action~|~chl1 gene~|~call (instruction)~|~call - dosing instruction fragment~|~decision~|~dependent - ability~|~endotracheal aspiration~|~external cause codes: unspecified~|~good~|~in addition to~|~meal (occasion for eating)~|~microplate well~|~not otherwise specified~|~pulmonary aspiration~|~specific qualifier value~|~status~|~unintentional material aspiration~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~well~|~well marginated nodule~|~what subject filter - status~|~with - dosing instruction fragment~|~withdraw (activity)~|~withdrawal (dysfunction)~|~withdrawal - birth control~|~withdrawal scale (basc-2)~|~withdrawal by subject~|~cytip gene